Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Market Videos
Currencies
International
Treasury & Bonds
Search InvestCenter
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
Dow Jones Industrial Average
NASDAQ Composite
Standard & Poors 500
NYSE COMPOSITE INDX
Gold
Crude Oil
Oncolytics Biotech, Inc.
(NQ:
ONCY
)
2.720
USD
+0.050 (+1.87%)
Official Closing Price
/ Updated:
8:10 PM EDT, May 21, 2013
/
Add to My Watchlist
View:
Quote
Overview
Detailed Quote
Charting
Options
Historical Prices
News
All News
Press Releases
Related Stories
Blogs
Podcasts
Research
Quarterly Reports
Insider Filings
Other Filings
Price and Volume
Detailed Quote
Intraday
1 Week
1 Month
3 Month
1 Year
Compare to:
None
S&P 500
Nasdaq
NYSE
AMEX
Russell 2000
Basic Materials
Conglomerates
Consumer Goods
Financial
Healthcare
Industrial Goods
Services
Technology
Utilities
Volume
0
Open
2.640
Bid (Size)
2.620 (800)
Ask (Size)
3.840 (100)
Prev. Close
2.670
Today's Range
2.640 - 2.759
52wk Range
1.600 - 4.930
Shares Outstanding
84,758,818
Dividend Yield
N/A
Top News
More News
Media Advisory - Oncolytics Biotech® Inc. to Present at Bank of America Merrill Lynch Health Care Conference
May 14, 2013
from
PR Newswire
Oncolytics Biotech® Inc. Announces Director Election Results from its Annual and Special Meeting of Shareholders
May 10, 2013
from
PR Newswire
More News
Read More
Oncolytics Biotech (ONCY) Posts Q1 Loss of 8c/Share
May 09, 2013
from
StreetInsider.com News Articles
Oncolytics Biotech® Inc. Announces First Quarter 2013 Results
May 09, 2013
from
PR Newswire
Oncolytics Biotech® Inc. Announces Details of 2013 Annual and Special Meeting of Shareholders
May 06, 2013
from
PR Newswire
Media Advisory - Oncolytics Biotech® Inc. to Present at 12th Annual Needham Healthcare Conference
April 29, 2013
from
PR Newswire
Free Research Reports on FINL, ONCY, PCS and RPRX Issued by the Bedford Report
April 01, 2013
from
Marketwired News Releases
StreetInsider.com Pre-Open Movers 03/28: (RPRX) (DECK) (XONE) Higher; (FIVE) (RHT) (GME) Lower (more...)
March 28, 2013
from
StreetInsider.com News Articles
Oncolytics (ONCY) REOLYSIN Met Primary Endpoint in Phase 2 on SCCLC
March 28, 2013
from
StreetInsider.com News Articles
Oncolytics Biotech® Inc. Meets Primary Overall Statistical Endpoint in U.S. Phase 2 Study of REOLYSIN® in Squamous Cell Lung Cancer
March 28, 2013
from
PR Newswire
Stock Market XML and JSON Data API
provided by FinancialContent Services, Inc.
Nasdaq quotes delayed at least 15 minutes, all others at least 20 minutes.
Markets are closed on certain holidays.
Stock Market Holiday List
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.
Press Release Service
provided by PRConnect.
Stock quotes supplied by Telekurs USA
Postage Rates
Bots go here